eXoZymes, Inc.
EXOZeXoZymes Inc. is a biotechnology company specializing in a proprietary cell-free biomanufacturing platform that utilizes AI-designed enzymes to produce high-value chemicals.
Earnings
Next report
Date not yet announcedValuation & ratios
Competitors
By market cap
By net margin
Profile
eXoZymes Inc. is a biotechnology company specializing in a proprietary cell-free biomanufacturing platform that utilizes AI-designed enzymes to produce high-value chemicals. The company's core value proposition lies in its ability to bypass the scalability and toxicity limitations of traditional synthetic biology by engineering complex biochemical pathways outside of living cells. This approach enables the sustainable and cost-effective production of natural products for the pharmaceutical, nutraceutical, and biofuel industries.
eXoZymes positions itself as a technological successor to synthetic biology, offering a more controllable and scalable cell-free platform for complex multi-step enzymatic conversions.
Questions, answered.
- What is eXoZymes, Inc.'s market cap?
- eXoZymes, Inc. (EXOZ) has a market capitalization of $65.7M and trades on NASDAQ.
- Who are eXoZymes, Inc.'s competitors?
- eXoZymes, Inc.'s key competitors include Gevo, Inc., Codexis, Inc., Ginkgo Bioworks, and others. These companies compete in similar markets and product categories.
- Who does eXoZymes, Inc. partner with?
- eXoZymes, Inc.'s notable partners include The Regents of the University of California, Bill & Melinda Gates Foundation, Shell, and others.
- What subsidiaries does eXoZymes, Inc. have?
- eXoZymes, Inc.'s subsidiaries include NCTX.
- Where is eXoZymes, Inc. headquartered?
- eXoZymes, Inc. is headquartered in United States of America. It has been publicly traded since 2024.